Centre Hospitalier Departemental Vendee
Clinical trials sponsored by Centre Hospitalier Departemental Vendee, explained in plain language.
-
Robotic seal brings comfort to seniors with dementia
Symptom relief TerminatedThis study looked at whether a robotic seal named PARO can help elderly people with moderate to severe memory problems who live in nursing homes. The goal was to see if the robot reduces difficult behaviors like agitation and anxiety, and whether it is worth the cost. The study p…
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 12, 2026 12:08 UTC
-
Sock study stumbles: only one patient enrolled
Symptom relief TerminatedThis study tested whether wearing non-slip socks helps older hospital patients walk better. The researchers planned to include people aged 75 and older who needed physical therapy and had poor footwear. However, only one person joined the study, so it was stopped early. No clear …
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 11, 2026 12:09 UTC
-
Personalized exercise for fibromyalgia: a study that never got off the ground
Symptom relief TerminatedThis study aimed to see if a personalized physical activity program could improve quality of life for people with fibromyalgia better than standard group exercise. Only one person enrolled, and the study was stopped early, so no conclusions can be drawn. The approach involved tai…
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 08, 2026 13:16 UTC
-
Blood marker studied to predict preterm birth risk
Knowledge-focused TerminatedThis study looked at whether a blood marker called procalcitonin can help predict which pregnant women hospitalized for threatened premature labor will actually deliver early. Researchers measured procalcitonin levels in 131 participants. The goal was to improve understanding of …
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Study reveals hidden diabetes risk from common transplant drug
Knowledge-focused TerminatedThis study aimed to understand how tacrolimus, a drug used to prevent organ rejection, affects blood sugar control in kidney failure patients before they receive a transplant. Researchers planned to enroll 61 adults on hemodialysis who were eligible for a kidney transplant. The g…
Phase: PHASE4 • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:04 UTC